Amrize (NYSE:AMRZ) Earns Hold (C) Rating from Weiss Ratings

Amrize (NYSE:AMRZ)‘s stock had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings in a report released on Thursday,Weiss Ratings reports.

A number of other research firms have also recently commented on AMRZ. Kepler Capital Markets raised Amrize to a “strong-buy” rating in a research note on Tuesday, October 21st. Wall Street Zen raised Amrize to a “hold” rating in a research note on Saturday, October 25th. Barclays started coverage on Amrize in a research note on Tuesday, October 7th. They issued an “equal weight” rating on the stock. JPMorgan Chase & Co. increased their target price on Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Finally, Morgan Stanley set a $61.00 target price on Amrize and gave the company an “overweight” rating in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $58.14.

Amrize Trading Down 0.4%

Shares of NYSE:AMRZ opened at $51.77 on Thursday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. Amrize has a 12 month low of $44.12 and a 12 month high of $56.29. The stock has a market capitalization of $28.63 billion and a PE ratio of 66.37. The company’s 50 day moving average price is $50.61.

Amrize (NYSE:AMRZ) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.03 by ($0.25). The business had revenue of $3.22 billion for the quarter.

Insider Activity at Amrize

In other news, insider Mario Gross bought 3,000 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was bought at an average cost of $49.63 per share, for a total transaction of $148,890.00. Following the completion of the acquisition, the insider owned 23,232 shares in the company, valued at approximately $1,153,004.16. This trade represents a 14.83% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Roald Brouwer bought 2,000 shares of the company’s stock in a transaction dated Wednesday, August 27th. The shares were purchased at an average price of $51.88 per share, with a total value of $103,760.00. Following the completion of the acquisition, the chief technology officer owned 5,000 shares of the company’s stock, valued at $259,400. This trade represents a 66.67% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 1,179,000 shares of company stock valued at $56,120,460 in the last quarter.

Institutional Trading of Amrize

Institutional investors have recently modified their holdings of the company. Global Retirement Partners LLC bought a new position in Amrize in the 3rd quarter worth $48,000. BNP Paribas Financial Markets bought a new position in Amrize in the 2nd quarter worth $59,000. Groupe la Francaise bought a new position in Amrize in the 2nd quarter worth $60,000. Allianz SE bought a new position in Amrize in the 2nd quarter worth $80,000. Finally, ASR Vermogensbeheer N.V. raised its holdings in Amrize by 2.3% in the 3rd quarter. ASR Vermogensbeheer N.V. now owns 72,577 shares of the company’s stock worth $3,502,000 after purchasing an additional 1,661 shares in the last quarter.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.